News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
498,454 Results
Type
Article (29528)
Company Profile (374)
Press Release (468547)
Multimedia
Podcasts (99)
Webinars (16)
Section
Business (135906)
Career Advice (427)
Deals (24646)
Drug Delivery (85)
Drug Development (66698)
Employer Resources (67)
FDA (12325)
Job Trends (9979)
News (238606)
Policy (19290)
Tag
Academia (1824)
Academic (1)
Accelerated approval (16)
Adcomms (20)
Allergies (108)
Alliances (37127)
ALS (136)
Alzheimer's disease (1456)
Antibody-drug conjugate (ADC) (262)
Approvals (12540)
Artificial intelligence (400)
Autoimmune disease (100)
Automation (26)
Bankruptcy (177)
Best Places to Work (8466)
BIOSECURE Act (15)
Biosimilars (142)
Biotechnology (263)
Bladder cancer (123)
Brain cancer (47)
Breast cancer (481)
Cancer (3837)
Cardiovascular disease (348)
Career advice (388)
Career pathing (14)
CAR-T (240)
CDC (8)
Cell therapy (641)
Cervical cancer (26)
Clinical research (56941)
Collaboration (1395)
Company closure (2)
Compensation (736)
Complete response letters (43)
COVID-19 (2071)
CRISPR (83)
C-suite (629)
Cystic fibrosis (122)
Data (4953)
Denatured (35)
Depression (100)
Diabetes (400)
Diagnostics (5047)
Digital health (32)
Diversity (8)
Diversity, equity & inclusion (19)
Drug discovery (197)
Drug pricing (78)
Drug shortages (16)
Duchenne muscular dystrophy (203)
Earnings (53237)
Editorial (32)
Employer branding (12)
Employer resources (61)
Events (85364)
Executive appointments (872)
FDA (14660)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (20)
Funding (1174)
Gene editing (178)
Generative AI (32)
Gene therapy (516)
GLP-1 (791)
Government (2526)
Grass and pollen (8)
Guidances (308)
Healthcare (12813)
HIV (40)
Huntington's disease (38)
IgA nephropathy (78)
Immunology and inflammation (200)
Immuno-oncology (21)
Indications (63)
Infectious disease (2259)
Inflammatory bowel disease (172)
Inflation Reduction Act (11)
Influenza (77)
Intellectual property (186)
Interviews (51)
IPO (12128)
IRA (23)
Job creations (1937)
Job search strategy (346)
Kidney cancer (13)
Labor market (39)
Layoffs (372)
Leadership (15)
Legal (3251)
Liver cancer (72)
Longevity (12)
Lung cancer (545)
Lymphoma (296)
Machine learning (32)
Management (17)
Manufacturing (537)
MASH (149)
Medical device (9211)
Medtech (9230)
Mergers & acquisitions (13368)
Metabolic disorders (976)
Multiple sclerosis (131)
NASH (17)
Neurodegenerative disease (251)
Neuropsychiatric disorders (64)
Neuroscience (2425)
NextGen: Class of 2025 (3689)
Non-profit (2677)
Now hiring (39)
Obesity (426)
Opinion (172)
Ovarian cancer (137)
Pain (127)
Pancreatic cancer (170)
Parkinson's disease (226)
Partnered (24)
Patents (364)
Patient recruitment (340)
Peanut (49)
People (43458)
Pharmaceutical (68)
Pharmacy benefit managers (9)
Phase I (18138)
Phase II (25024)
Phase III (18880)
Pipeline (3187)
Policy (143)
Postmarket research (1831)
Preclinical (7568)
Press Release (60)
Prostate cancer (195)
Psychedelics (49)
Radiopharmaceuticals (255)
Rare diseases (644)
Real estate (3698)
Recruiting (28)
Regulatory (16631)
Reports (27)
Research institute (1885)
Resumes & cover letters (47)
Rett syndrome (22)
RNA editing (16)
RSV (46)
Schizophrenia (125)
Series A (200)
Series B (146)
Service/supplier (6)
Sickle cell disease (85)
Special edition (19)
Spinal muscular atrophy (142)
Sponsored (34)
Startups (2700)
State (1)
Stomach cancer (11)
Supply chain (78)
Tariffs (34)
The Weekly (63)
Vaccines (705)
Venture capital (59)
Weight loss (265)
Women's health (54)
Worklife (3)
Date
Last 7 days (492)
Last 30 days (2137)
Last 365 days (26534)
2025 (25212)
2024 (30154)
2023 (33607)
2022 (43710)
2021 (46640)
2020 (42593)
2019 (32186)
2018 (24094)
2017 (24507)
2016 (22908)
2015 (26833)
2014 (20021)
2013 (15812)
2012 (16606)
2011 (16263)
2010 (14959)
Location
Africa (453)
Alabama (67)
Alaska (4)
Arizona (146)
Arkansas (11)
Asia (31840)
Australia (5519)
California (8709)
Canada (2492)
China (932)
Colorado (355)
Connecticut (347)
Delaware (279)
Europe (71994)
Florida (1183)
Georgia (295)
Hawaii (3)
Idaho (36)
Illinois (585)
India (55)
Indiana (421)
Iowa (14)
Japan (343)
Kansas (102)
Kentucky (20)
Louisiana (14)
Maine (40)
Maryland (1053)
Massachusetts (6739)
Michigan (277)
Minnesota (415)
Mississippi (4)
Missouri (98)
Montana (29)
Nebraska (13)
Nevada (80)
New Hampshire (60)
New Jersey (2489)
New Mexico (25)
New York (2310)
North Carolina (1138)
North Dakota (9)
Northern California (4152)
Ohio (241)
Oklahoma (18)
Oregon (31)
Pennsylvania (1776)
Puerto Rico (17)
Rhode Island (34)
South America (637)
South Carolina (19)
Southern California (3386)
Tennessee (108)
Texas (1199)
United States (30978)
Utah (181)
Virginia (197)
Washington D.C. (62)
Washington State (724)
West Virginia (2)
Wisconsin (71)
Wyoming (2)
498,454 Results for "global blood therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ernexa Therapeutics to Present at Oxford Global’s Cell 2025
November 12, 2025
·
2 min read
Press Releases
Aditxt Subsidiary Pearsanta Begins Enrollment in First Human Study of Blood-Based Diagnostic for Endometriosis, a Condition Affecting 190 Million Women Worldwide and Representing a $1.45 Billion Global Market
October 28, 2025
·
6 min read
Press Releases
Onward Therapeutics Completes Share Exchange and Establishes Global Headquarters in Taiwan
November 10, 2025
·
3 min read
Press Releases
Alethio Therapeutics Launches with New CEO and Chair to Advance Two Targeted Medicines for Myeloproliferative Neoplasms (Chronic Blood Cancers)
October 30, 2025
·
8 min read
Press Releases
Tango Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference
November 13, 2025
·
1 min read
Press Releases
Beacon Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference
November 13, 2025
·
1 min read
Press Releases
Nektar Therapeutics to Participate in the Jefferies Global Healthcare Conference 2025 in London
October 31, 2025
·
1 min read
Press Releases
Parse Biosciences Launches Evercode Whole Blood Fixation
December 4, 2025
·
2 min read
Press Releases
Whitehawk Therapeutics to Present at Jefferies 2025 Global Healthcare Conference in London
November 11, 2025
·
1 min read
Press Releases
Chiesi Group Enters into an Exclusive License Agreement with Aliada Therapeutics, a Wholly Owned Subsidiary of AbbVie, to Advance Blood-Brain Barrier-Crossing Platform Technology in Lysosomal Storage Disorders
November 13, 2025
·
3 min read
1 of 49,846
Next
